Middle East & Africa Neurorehabilitation Devices Market

Historic Data: 2021-2023   |   Base Year: 2023   |   Forecast Period: 2025-2031

Analysis - by Product Type (Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, and Wearable Devices), Application (Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson's Disease, Cerebral Palsy, and Others), and End User (Rehabilitation Centers, Hospitals and Clinics, and Home Care)

No. of Pages: 117
Report Code: BMIRE00031468
Category: Life Sciences
Middle East & Africa Neurorehabilitation Devices Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Middle East & Africa Neurorehabilitation Devices Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Middle East & Africa Neurorehabilitation Devices Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Middle East & Africa Neurorehabilitation Devices Market Regional Analysis

6.2 Middle East & Africa Neurorehabilitation Devices Market Revenue 2021-2031 (US$ Million)
6.3 Middle East & Africa Neurorehabilitation Devices Market Forecast Analysis

7. Middle East & Africa Neurorehabilitation Devices Market Analysis – by Product Type

7.1 Neurorobotic System
  • 7.1.1 Overview
  • 7.1.2 Neurorobotic System: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Brain Computer Interface
  • 7.2.1 Overview
  • 7.2.2 Brain Computer Interface: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Non-invasive Stimulators
  • 7.3.1 Overview
  • 7.3.2 Non-invasive Stimulators: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Wearable Devices
  • 7.4.1 Overview
  • 7.4.2 Wearable Devices: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Middle East & Africa Neurorehabilitation Devices Market Analysis – by Application

8.1 Stroke
  • 8.1.1 Overview
  • 8.1.2 Stroke: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Traumatic Brain Injury
  • 8.2.1 Overview
  • 8.2.2 Traumatic Brain Injury: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Spinal Cord Injury
  • 8.3.1 Overview
  • 8.3.2 Spinal Cord Injury: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Parkinson\'s Disease
  • 8.4.1 Overview
  • 8.4.2 Parkinson\'s Disease: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Cerebral Palsy
  • 8.5.1 Overview
  • 8.5.2 Cerebral Palsy: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Middle East & Africa Neurorehabilitation Devices Market Analysis – by End User

9.1 Rehabilitation Centers
  • 9.1.1 Overview
  • 9.1.2 Rehabilitation Centers: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Hospitals and Clinics
  • 9.2.1 Overview
  • 9.2.2 Hospitals and Clinics: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Home Care
  • 9.3.1 Overview
  • 9.3.2 Home Care: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Middle East & Africa Neurorehabilitation Devices Market – Middle East & Africa Analysis

10.1 Overview

10.2 Middle East & Africa
  • 10.2.1 Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Key Country, 2025 and 2031 (%)
  • 10.2.1.1 Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 Saudi Arabia: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.1.1 Saudi Arabia: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Product Type
    • 10.2.1.1.2 Saudi Arabia: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Application
    • 10.2.1.1.3 Saudi Arabia: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by End User
  • 10.2.1.2 the UAE: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.2.1 the UAE: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Product Type
    • 10.2.1.2.2 the UAE: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Application
    • 10.2.1.2.3 the UAE: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by End User
  • 10.2.1.3 South Africa: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.3.1 South Africa: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Product Type
    • 10.2.1.3.2 South Africa: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Application
    • 10.2.1.3.3 South Africa: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by End User
  • 10.2.1.4 Rest of Middle East & Africa: Middle East & Africa Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.2.1.4.1 Rest of Middle East & Africa: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Product Type
    • 10.2.1.4.2 Rest of Middle East & Africa: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by Application
    • 10.2.1.4.3 Rest of Middle East & Africa: Middle East & Africa Neurorehabilitation Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Abbott Laboratories
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 BIONIK
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 BioXtreme Ltd
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Blackrock Microsystems Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Ekso Bionics Holdings Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 EMOTIV
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Hocoma AG
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Medtronic Plc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Renishaw Plc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Tyromotion GmbH
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Middle East & Africa Neurorehabilitation Devices Market

  • Abbott Laboratories
  • BIONIK
  • BioXtreme Ltd
  • Blackrock Microsystems Inc
  • Ekso Bionics Holdings Inc
  • EMOTIV
  • Hocoma AG
  • Medtronic Plc
  • Renishaw Plc
  • Tyromotion GmbH
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)